Our values
Corporate Social Responsibility
CSR is a lever for transformation that strengthens the company’s performance, attractiveness and long-term sustainability. It supports CROSSJECT at every stage of its growth.
Corporate Social Responsibility (CSR) means integrating social, environmental and economic issues into the company’s activities.
For CROSSJECT, CSR supports the company’s development by reconciling growth, competitiveness and responsibility. CSR aims to ensure the well-being of employees by fostering an attractive and motivating work environment, while strengthening the company’s ability to attract and retain talent.
This approach also helps optimise certain expenses through better control of resources, and reduces the company’s environmental footprint. Anticipating regulations is a key focus of CSR. By structuring its responsible practices today, CROSSJECT meets the expectations of its stakeholders while preparing for its future. CSR is therefore not only a societal commitment, but also a key success factor in the company’s growth.
“The recognition of our strong commitment and our daily mission to save lives motivates the entire CROSSJECT team in this CSR ambition.”
“CSR is the foundation of a sustainable and viable economy, enabling the sharing of common sense and highlighting a unique concept that saves lives.”
Responsible Care
In October 2019, CROSSJECT signed the Responsible Care® charter, a global chemical industry initiative, to formalize its commitment to corporate social responsibility.
Procurement & CSR
“Suppliers are beginning to discuss innovations supporting CSR. The dialogue must take place across the entire value chain.”
and Legal Affairs
-
A procurement process based on three pillars: equality, fairness and transparency in treatment.
-
A supplier panel primarily composed of French companies manufacturing in France.
-
Supplier proposals qualified through discrimination criteria, including a CSR rating.
Ethical charter
This is a major objective for CROSSJECT, forming an integral part of each of our values, to continually enhance the trust everyone places in our company.
The ethical charter of our company embodies our commitment to conducting business with integrity, transparency, and responsibility. It serves as the foundation of our corporate culture, guiding the actions and decisions of our employees, partners, and stakeholders.
Acting ethically, particularly by respecting the Universal Declaration of Human Rights, and adhering to all rules governing our activities, must be a goal for everyone and each of us individually.
CROSSJECT has obtained the EthiFinance 2024 certificate
Silver Level
To reward its ESG performance in 2023
A measured commitment
CROSSJECT is ranked in the TOP 5 of the “Health Equipment and Services” subsector.
The CSR policy of listed companies is evaluated annually by EthiFinance, a European agency specializing in ESG (Environmental, Social, and Governance) performance ratings. Aligning our strategy with the Gaïa framework (evaluation of 250 CSR criteria) is an asset for investors and public actors. This commitment demonstrates our maturity and continuous progress in the index, reflecting our mastery of the levers as an innovative pharmaceutical company. We follow a strict approach, yet one inspired by the reality of field experience, which sets progress goals while allowing significant autonomy to the actors.
A recognized commitment
-
France Chimie Responsible Care Award: On April 11, 2022, CROSSJECT received the special jury award at the “4th Chemistry Meeting” organized by France Chimie Auvergne-Rhône-Alpes.
-
Winner of the RSE Trophies for the Bourgogne-Franche-Comté region, in the category of Fair Business Practices – 2021 Edition.
-
Challenge Mobilité Bourgogne-Franche-Comté: Winner in the category of 50 to 249 employees in December 2024. Over 4,500 km traveled using sustainable mobility between September 16 and 20, 2024.